The U.S. contraceptive market size is expected to reach USD 9.6 billion by 2027, exhibiting a 4.2% CAGR over the forecast period, based on a new report published by Grand View Research, Inc. Improving awareness regarding Long-Acting Reversible Contraceptives (LARCs) and effectiveness, availability, and convenience of using these products are the factors expected to drive the growth. The Guttmacher Institute reports that in U.S., 60% of women of reproductive age use contraception. Use of hormonal contraceptives other than the birth control pill has significantly increased among married women.
Key market players are actively investing in the clinical pipeline, resulting in high competition and an increase in the quality of contraceptives. In January 2019, Mithra Pharmaceuticals announced the success of Estelle’s phase 3 study conducted in U.S. and Canada, meeting the primary efficacy endpoint. The efficacy was reported to be similar to a recently FDA-approved Annovera and Lo-Loestrin. In November 2019, Agile Therapeutics, Inc. announced that the U.S. FDA had extended the review date of Twirla’s New Drug Application (NDA), from November 16, 2019 to February 16, 2020.
To Know More About U.S. Contraceptive Market, Access Sample Report @ https://www.grandviewresearch.com/industry-analysis/us-contraceptive-market/request/rs1
Further key findings from the study suggest:
Browse Details of Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/us-contraceptive-market
Grand View Research has segmented the U.S. contraceptive market based on product:
U.S. Contraceptive Product Outlook(Revenue, USD Million, 2016 – 2027)
Key Topics Covered
Table of Content
Chapter 1 Methodology and Scope 1.1 Objectives 1.1.1. Objective – 1 1.1.2 Objective – 2 Chapter 2 Executive Summary 2.1 Market Outlook 2.2 Segment Outlook 2.2.1 Product 2.3 Competitive Insights Chapter 3 Market Variables, Trends & Scope 3.1 Market Lineage outlook 3.1.1 Parent Market Outlook 3.2 Market Segmentation 3.3 Market Dynamics 3.3.1 Market Driver Analysis 3.3.1.1 Technological advancements 3.3.1.2 Initiatives by social organizations to improve the access of condom to avoid Sexually Transmitted Diseases (STDs) 3.3.1.3 Increasing Prevalance of unwanted pregnancies 3.3.2 Market Restraint Analysis 3.3.2.1 Increasing geriartic population and rising prevalence of infertility 3.3.2.2 Adverse effects associated with use of contraceptive drugs and devices 3.4 Business Environment Analysis Tools 3.4.1 Porter’s Five Forces Analysis 3.4.2 PESTEL Analysis 3.5 Penetration & Growth Prospect Mapping
…. continue
Browse Related Reports : Hormonal Contraceptive Market By Method (Pill, Intrauterine Device (IUD), Patch, Implant, Vaginal Ring, Injectable), By Region, And Segment Forecasts, 2019 – 2026:
https://www.grandviewresearch.com/industry-analysis/hormonal-contraceptive-market
Subdermal Contraceptive Implants Market By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2019 – 2026:
https://www.grandviewresearch.com/industry-analysis/subdermal-contraceptive-implants-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: https://www.grandviewresearch.com/industry-analysis/us-contraceptive-market